U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

CorMedix, Inc. (CRMD)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.47+0.05 (+11.37%)
At close: 4:00PM EDT

0.51 +0.04 (8.51%)
After hours: 7:05PM EDT

People also watch
SYNZIOPFCSCAXNANTH

CorMedix, Inc.

1430 US Highway 206
Suite 200
Bridgewater, NJ 07921
United States
908-517-9500
http://www.cormedix.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees14

Key Executives

NameTitlePayExercisedAge
Mr. Khoso BaluchCEO & Director208.32kN/A59
Mr. Robert W. CookChief Financial OfficerN/AN/A61
Mr. John L. Armstrong Jr., MBAHead of HR and Exec. VP of Technical OperationsN/AN/A73
Mr. John OrtizVP of Regulatory Affairs and Quality AssuranceN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and other markets. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Bridgewater, New Jersey.

Corporate Governance

CorMedix, Inc.’s ISS Governance QualityScore as of September 1, 2017 is 7. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 2; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.